CMEonCD
My Account Programs Courses
  Home
   


  

Produced in partnership with
The Society for
Cardiac Angiography and Interventions
 
www.scai.org

View SCAI Privacy Policy

Computer Requirements
 
View Recording of Event
Complete post-evaluation
E-mail your questions
 
 

You will need:


Live Panel Discussion!

Masters in Medicine: Optimal Anticoagulation Strategies for Percutaneous Intervention

This event was recorded on:
Thursday, March 27, 2003

Supported by an unrestricted educational grant from:


www.pharmacia.com

 

Powered by

View recording of event



Frederick Feit, MD, FACC
Associate Professor of Medicine and Director
Cardiac Catheterization Intervention
New York Medical Center, New York, NY

Disclosures:No financial relationships with a commercial party to disclose.

David J. Moliterno, MD
Associate Professor of Medicine
The Cleveland Clinic Foundation
Cleveland, OH
Disclosures: Consultant: Pharmanetics; Research and Grant Support: Eli Lilly and Company.

 

Stephen R. Steinhubl, MD
Division of Cardiology, School of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC

Disclosures: Research support, consultant: Bristol-Myers Squibb, Sanofi-Synthelabo, Aventis; Research support: Medicines Company; Consultant: Merck, Eli Lilly and Company

Moderator:
Joseph D. Babb, MD, FACC, FSCAI

Professor of Medicine
East Carolina University School of Medicine
Director, Cardiac Catheterization Laboratories
Pitt County Memorial Hospital
Greenville, NC
Disclosures:No financial relationships with a commercial party to disclose.


Overview

Course length: 1 hour

The use of percutaneous coronary intervention (PCI) has increased dramatically, becoming one of the most common medical interventions performed today. Unfractionated heparin has traditionally been the anticoagulant of choice for prevention of thrombus formation during PCI. However, the adjunct use of potent antithrombotic agents has further improved clinical outcomes in patients undergoing PCI.

Has the use of heparin therapy become passé in the cath lab? Has the use of newer agents (i.e., low-molecular-weight heparin, glycoprotein IIb/IIIa antagonists, direct thrombin inhibitors, thienopyridine) become the standard of care? Join recognized experts in this lively discussion as they review current treatment recommendations for antithrombotic therapy during PCI based on the available clinical evidence.


Learning Objectives

Upon completion of this course, you will be able to:

  • Discuss the use of adjunct therapy in PCI
  • Understand the appropriate use and indications of the various adjunct therapies available
  • Discuss and apply the relevance of the clinical trials presented in selecting an appropriate management plan for an individualized patient

Learner Participation to Earn Credit

To earn a CME certificate, you must:

Computer Requirements to Participate

Click here to view the computer requirements to participate in this activity.

Target Audience

The following CME course is designed for physicians who practice interventional cardiovascular medicine as well as any physician involved in the management of patients undergoing percutaneous coronary intervention.

Accreditation Period

This activity was approved for AMA category 1 credit for two years from the original release date of March 27, 2003. After March 27, 2005 it will no longer be certified for credit, but may still have value for the healthcare provider.

Accreditation Statement

Continuing Medical Education for Physicians
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The Society for Cardiac Angiography and Interventions (SCAI) and CEU-Online. The SCAI is accredited by the ACCME to provide continuing medical education for physicians.

The Society for Cardiac Angiography and Interventions designates this educational activity for a maximum of one category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only the credit that he/she actually spent in the activity.

Questions Regarding This Event

Please click here to e-mail any questions you have regarding this activity.

As an organization accredited for continuing medical education (CME), SCAI fully complies with the legal requirements of the Americans with Disabilities Act rules and regulations. If any participant is in need of accommodations, written requests should be submitted as soon as possible.


Course Certificate Fees

This course certificate is FREE to all qualified participants.

(C) 2003, Medical Education Broadcast Network. All Rights Reserved.